
TriLogic Pharma: Innovating drug delivery platforms for human and animal health since 2000.
Founded in 2000 and based in Tallassee, Alabama, TriLogic Pharma specializes in developing and marketing innovative drug delivery platforms for both human and animal health. The company's core mission is to enhance therapeutic outcomes by overcoming the limitations of traditional systemic and oral antibiotic therapies, such as joint pain and gastric discomfort. TriLogic Pharma's flagship product is an in-situ gel that provides localized treatment, improving patient compliance and tolerability.
TriLogic Pharma has made significant strides in the pharmaceutical industry with its advanced hydrogel technology, which features in-situ gelation and bioresorption with adhesion. The company has garnered attention from notable investors and industry experts due to its groundbreaking approach to drug delivery. TriLogic Pharma's impact is evident in its contribution to better therapeutic compliance and overall patient well-being, setting new standards in both human and veterinary medicine.

Tris Pharma
trispharma.com

InSitu Biologics

Talima Therapeutics
talima.com

Toralgen
toralgen.com

Concours Pharmaceuticals

PharmaIN
pharmain.com

Intact Therapeutics

Trigemina
Protect Pharmaceutical

Trilo Therapeutics

Fidelis Pharmaceuticals
fidelisrx.com

Triagenics
triagenics.com

Theracos
theracos.com

NovaDel Pharma

Trim-Edicine
trim-edicine.com
Companies similar to Trilogic Pharma include Tris Pharma, InSitu Biologics, Talima Therapeutics and Toralgen.
Trilogic Pharma was founded in 2000.
Trilogic Pharma's headquarters is located in Montgomery, AL, US.
Trilogic Pharma's most recent funding round was for $222.9k (USD) in August 2012.
As of Aug 1, 2012, Trilogic Pharma has raised a total of $3M (USD).
Trilogic Pharma has 6 employees as of Feb 5, 2024.